Puma Biotechnology Inc (PBYI)
4.88
+0.05
(+1.04%)
USD |
NASDAQ |
Apr 25, 16:00
4.875
0.00 (0.00%)
Pre-Market: 20:00
Puma Biotechnology Shareholders Equity (Quarterly): 53.44M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 53.44M |
September 30, 2023 | 38.74M |
June 30, 2023 | 30.40M |
March 31, 2023 | 25.85M |
December 31, 2022 | 21.61M |
September 30, 2022 | 22.16M |
June 30, 2022 | 19.74M |
March 31, 2022 | 7.145M |
December 31, 2021 | -2.446M |
September 30, 2021 | -10.92M |
June 30, 2021 | 29.47M |
March 31, 2021 | 16.44M |
December 31, 2020 | -5.951M |
September 30, 2020 | -0.453M |
June 30, 2020 | 23.40M |
March 31, 2020 | 9.377M |
December 31, 2019 | 17.46M |
September 30, 2019 | 17.18M |
June 30, 2019 | 21.77M |
March 31, 2019 | 43.47M |
December 31, 2018 | 34.31M |
September 30, 2018 | 45.91M |
June 30, 2018 | 38.30M |
March 31, 2018 | 57.46M |
December 31, 2017 | 53.30M |
Date | Value |
---|---|
September 30, 2017 | 79.17M |
June 30, 2017 | 120.11M |
March 31, 2017 | 167.39M |
December 31, 2016 | 209.82M |
September 30, 2016 | 91.15M |
June 30, 2016 | 127.08M |
March 31, 2016 | 164.94M |
December 31, 2015 | 206.01M |
September 30, 2015 | 244.84M |
June 30, 2015 | 274.78M |
March 31, 2015 | 304.34M |
December 31, 2014 | 117.05M |
September 30, 2014 | 141.60M |
June 30, 2014 | 167.04M |
March 31, 2014 | 198.79M |
December 31, 2013 | 83.99M |
September 30, 2013 | 94.76M |
June 30, 2013 | 107.02M |
March 31, 2013 | 118.28M |
December 31, 2012 | 128.91M |
September 30, 2012 | 9.002M |
June 30, 2012 | 28.04M |
March 31, 2012 | 42.60M |
December 31, 2011 | 54.37M |
September 30, 2011 | 0.00 |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.92M
Minimum
Sep 2021
53.44M
Maximum
Dec 2023
17.60M
Average
19.74M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
ADMA Biologics Inc | 135.21M |
Regeneron Pharmaceuticals Inc | 25.97B |
Sarepta Therapeutics Inc | 859.34M |
CytomX Therapeutics Inc | -47.45M |
Mirum Pharmaceuticals Inc | 248.67M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 230.53M |
Total Liabilities (Quarterly) | 177.09M |
Debt to Equity Ratio | 1.865 |
Current Ratio | 1.572 |
Net Debt Paydown Yield | -0.16% |